Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03245151
Title Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Eisai Inc.


Advanced Solid Tumor

high grade glioma

Ewing sarcoma


Everolimus + Lenvatinib

Age Groups: adult | child
Covered Countries USA | CAN

No variant requirements are available.